Concepedia

Emmanuel Nwangele

EN

Statistics

Publications

4

Citations

56

H-Index

4

Active since

2023

Affiliations

University of Saskatchewan(Current)

Royal University Hospital

Hôtel-Dieu de Québec

Université Laval

Centre hospitalier de l'Université Laval

Emmanuel Nwangele is an author at University of Saskatchewan specializing in oncology, molecular oncology, and theranostic approaches.

ORCID

Publications per year

2023–2025

4

Publications

4

Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics

Jessica Pougoue Ketchemen, Hanan Babeker, Anjong Florence Tikum et al. · British Journal of Cancer · 2023 · 16 citations · Full text

, , +14

Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer

Jessica Pougoue Ketchemen, Fabrice Ngoh Njotu, Hanan Babeker et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 16 citations

, , +11

Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody–Drug Radioconjugate

Jessica Pougoue Ketchemen, Fabrice Ngoh Njotu, Hanan Babeker et al. · Clinical Cancer Research · 2024 · 13 citations

, , +17

<sup>225</sup> Ac/ <sup>89</sup> Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4–Positive Triple-Negative Breast Cancer

Hanan Babeker, Fabrice Ngoh Njotu, Jessica Pougoue Ketchemen et al. · Journal of Nuclear Medicine · 2025 · 11 citations · Full text

, , +17

1–4 of 4